Skip to content
Our 2022 Year in Review is now live.
  • Insights

      Weekly Bulletin

      Your weekly recap of news and analysis from the psychedelic sector.

      Read the Latest

      Research Review

      A monthly review of the most important psychedelics research.

      Review Archive

      News & Interviews

      The latest news from across the psychedelics space.

      Explore Now
  • Data

      Psychedelics Patent Trackers

      We track the latest patents and filings related to psilocybin, MDMA and DMT.

      Psilocybin Patents
      Psilocybin Patent Filings
      LSD Patents
      MDMA Patents
      DMT Patents
      Psilocybin Patents
      Psilocybin Patent Filings
      LSD Patents
      MDMA Patents
      DMT Patents

      Psychedelic Legalization & Decriminalization Tracker

      Mapping psychedelic drug policy reform across the United States

      Explore the Tracker
      New: Oregon Local Jurisdiction Tracker

      Psychedelics Drug Development Tracker

      From drug discovery to regulatory approval, we map drug development in psychedelics.

      Explore the Tracker
  • Companies

      Stocks & Companies Directory

      A directory of all the major psychedelics stocks, companies and ETFs.

      Access Directory

      Sector Landscape Map

      Explore the Psychedelic Sector Landscape visually using our new tool.

      Explore Now

      Stock Watchlist

      A one-stop overview of psychedelics stocks financial performance.

      Explore Now
  • Psychedelic Careers
  • Contact
Search
Close
Read more about the article Levitee Labs Announces Philip Van Den Berg to Join as Interim CEO and the Board of Directors and Close First Tranche of Private Placement for $1.5 Million

Levitee Labs Announces Philip Van Den Berg to Join as Interim CEO and the Board of Directors and Close First Tranche of Private Placement for $1.5 Million

  • Post published:February 1, 2022
  • Post category:Press Release
Read more about the article Levitee Labs Announces Medical Advisory Board

Levitee Labs Announces Medical Advisory Board

  • Post published:January 6, 2022
  • Post category:Press Release
Read more about the article Levitee Labs Appoints Dr. Mohammed Mosli as Chief People Officer of Levitee Clinics and Pharmacies in Alberta, Canada

Levitee Labs Appoints Dr. Mohammed Mosli as Chief People Officer of Levitee Clinics and Pharmacies in Alberta, Canada

  • Post published:October 14, 2021
  • Post category:Press Release
Read more about the article Levitee Labs Announces DTC Eligibility Approval

Levitee Labs Announces DTC Eligibility Approval

  • Post published:September 24, 2021
  • Post category:Press Release
Read more about the article Levitee Labs Commences Trading in U.S. Under Ticker LVTTF

Levitee Labs Commences Trading in U.S. Under Ticker LVTTF

  • Post published:September 9, 2021
  • Post category:Press Release
Read more about the article Levitee Labs Appoints NIH Physician-Scientist Dr. Fady Hannah-Shmouni as Chief Medical and Scientific Officer

Levitee Labs Appoints NIH Physician-Scientist Dr. Fady Hannah-Shmouni as Chief Medical and Scientific Officer

  • Post published:August 5, 2021
  • Post category:Press Release
Read more about the article Levitee Labs Acquires Five Addiction Clinics in Alberta

Levitee Labs Acquires Five Addiction Clinics in Alberta

  • Post published:July 29, 2021
  • Post category:Press Release
Read more about the article Levitee Labs Acquires Three Specialized Alberta Pharmacies

Levitee Labs Acquires Three Specialized Alberta Pharmacies

  • Post published:July 29, 2021
  • Post category:Press Release
Read more about the article Levitee Labs Announces Completion of Acquisition of BlockMD Telemedicine Platform

Levitee Labs Announces Completion of Acquisition of BlockMD Telemedicine Platform

  • Post published:July 28, 2021
  • Post category:Press Release
Read more about the article Levitee Labs Signs Definitive Agreements to Acquire Clinics, Pharmacies, and a Telemedicine Company in Alberta

Levitee Labs Signs Definitive Agreements to Acquire Clinics, Pharmacies, and a Telemedicine Company in Alberta

  • Post published:July 23, 2021
  • Post category:Press Release

End of content

No more pages to load

Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Psychedelic Stocks and Companies
  • News & Interviews
  • Psychedelic Sector Jobs
  • Data Bank

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

  • Psychedelic Alpha © 2022, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Join Our Newsletter

Psychedelic sector insights, interviews and analysis delivered to your inbox.

No thanks, continue to site.